您好,欢迎来到皮书数据库!
热点推荐: 双循环
更多>> 课题组动态
更多>> 皮书作者
谢伏瞻
    中国社会科学院学部委员,学部主席团主席,研究员,博士生导师。历任中国社会科学院院长、党组书记,国务院发展中心副主... 详情>>
蔡 昉
    中国社会科学院国家高端智库首席专家,学部委员,学部主席团秘书长,研究员,博士生导师。先后毕业于中国人民大学、中国... 详情>>
李培林
    男,汉族,出生于1955年5月,山东济南人,博士,研究员,全国人民代表大会社会建设委员会副主任委员,中国社会科学... 详情>>

    20世纪40年代~2020年我国解热镇痛药产销概况及前景展望

    摘要

    解热镇痛药现在已成为全世界医药市场应用面最广、应用量最大的大宗医药品种之一,也是人们日常生活中必不可少的常用药品。我国生产解热镇痛药已有80余年历史,尤其是改革开放几十年来,我国解热镇痛药产销量一直保持快速增长的趋势,现已成为全球解热镇痛药的最重要的生产和出口基地之一,在国际市场上占有举足轻重的地位。本文分析了当前我国解热镇痛药产业面临的一些新情况以及存在的亟待解决的问题,并提出企业要在提高技术水平、调整优化结构、加强环保治理、打造品牌产品等方面做进一步的努力,从解热镇痛药生产大国加速向生产强国转变。

    <<
    >>

    Abstract

    Antipyretic and analgesic drugs have now become one of the most widely used and the most used bulk medicines in the global pharmaceutical market,and they are also commonly used drugs that are indispensable in people’s daily lives. China has been producing antipyretic and analgesic drugs for more than 80 years. Especially since the reform and opening up,the production and sales of antipyretic and analgesic drugs in China have maintained a rapid growth trend,and China has become the most important production and export base of antipyretic and analgesic drugs in the world,occupying a pivotal position in the international market. This paper analyzes some new situations and problems to be solved by the antipyretic and analgesic industry in China,and proposes that enterprises should make further efforts in improving technical levels,adjusting and optimizing structures,strengthening environmental protection,and creating branded products,in order to accelerate the transformation from a major manufacturing country of antipyretic and analgesic drugs to a strong manufacturing country.

    <<
    >>
    作者简介
    张伦:张伦,工程师,南京制药厂研究所,专注于药品生产工艺及市场发展等方面的研究。
    <<
    >>
    相关报告